Shares of Lumentum Holdings surged as much as 10.1% to $832.24 Monday after StoneX initiated coverage with a Buy rating and a $1,200 price target, handing investors a lifeline following a bruising stretch that saw the stock lose nearly 12% in a single session last week. Lumentum Soars 10% on a Bullish New Analyst Call — But With Products Sold Out for Three Years, Is $1,200 Bold Enough?
Shares of Lumentum Holdings jumped 10.1% to $832.24 Monday after StoneX initiated coverage with a Buy rating and a $1,200 price target, implying an additional 44% upside from current levels. The call arrived after a volatile stretch — the stock cratered 11.5% on October 22 before partially recovering — and gave investors a concrete reason to buy the dip.
• Wall Street Is Overwhelmingly Bullish, and StoneX Joined a Crowded Chorus
Of the 27 analysts covering Lumentum, 22 rate it a Buy, 5 a Hold, and none a Sell.
The median 12-month price target sits at $1,200. StoneX's new target matches the consensus middle, not the frontier. Bernstein recently set a $1,220 target, Stifel raised to $1,232, and Jefferies lifted to $1,250 — meaning StoneX's note validates the thesis rather than extending it. For shareholders, the significance is timing: the initiation arrested a sharp selloff and pulled bargain hunters off the sidelines.
• Revenue Is Doubling and the Company Literally Cannot Make Enough Product
Q4 fiscal 2026 revenue reached $1.01 billion, up 109% year-over-year , and the company is guiding fiscal Q1 2027 revenue of $1.225 billion to $1.275 billion with non-GAAP operating margins of 39.5% to 40.5%. Perhaps more important: CEO Michael Hurlston told Bloomberg that Lumentum's optical components are sold out through early 2029, as tech companies race to build faster AI data centers.
The company can't meet roughly 70% of demand for some products through next year and faces a 30% shortfall on others through 2028. That backlog is rare pricing power.
• Margins Are Expanding Fast, but the Stock Isn't Cheap
Non-GAAP gross margin exceeded 50%, and operating margin expanded by over 2,150 basis points (roughly 21.5 percentage points) year-over-year. Yet Lumentum's price-to-sales ratio — stock price relative to revenue per share — stands at 30.2, far above its historical median of 3.35. Meanwhile, insiders sold $175.8 million in shares over the past 12 months with no insider buying reported. Investors are paying a steep premium for growth that must be sustained for years.
• New Factories Won't Ease Shortages Until 2029 at the Earliest
Lumentum is adding capacity through a new fabrication facility in Greensboro, North Carolina, and an expansion of a second fab in Japan. But Hurlston warned that new laser capacity takes about three years to reach customers, placing meaningful relief no earlier than 2029 to 2030. That long lead time cuts both ways: it protects pricing today but limits how fast the company can capture surging AI demand.